Wayne K. Goodman, MD, Honored with Mysell Lecture By Harvard Medical School

Wayne K. Goodman, MD, Chair of the Department of Psychiatry at Mount Sinai, has been selected to deliver the prestigious Mysell Lecture at Harvard.

New York, NY
 – March 24, 2010 /Press Release/  –– 

Wayne K. Goodman, MD, Chair of the Department of Psychiatry and the Esther and Joseph Klingenstein Professor of Psychiatry in the Department of Neuroscience at The Mount Sinai Medical Center, has been selected to deliver the prestigious Mysell Lecture at Harvard Medical School.

In a presentation titled “Recent History and Current Status of Obsessive-Compulsive Disorder Research,” Dr. Goodman will discuss current diagnosis and treatment of obsessive-compulsive disorder (OCD), and discuss ongoing research on the disorder. His talk will be held Wednesday, March 24, during the Harvard Psychiatry Research Day.

Previous Mysell lecturers, selected by the Harvard Psychiatry Executive Committee, include Nobel laureate Eric Kandel, MD; Floyd Bloom, MD; Thomas Insel, MD, and Nora Volkow, MD.

“It is an honor for Dr. Goodman to be invited to give this address,” said Dennis Charney, M.D., Anne and Joel Ehrenkranz Dean of Mount Sinai School of Medicine and Executive Vice President for Academic Affairs at The Mount Sinai Medical Center. “His ground-breaking research and contributions to psychiatry make him a true asset to Mount Sinai and to the field.”

Since joining Mount Sinai in July 2009, Dr. Goodman has worked closely with the Friedman Brain Institute to conduct research on neuropsychiatric disorders such as schizophrenia, Alzheimer's disease, and bipolar disorder. Before coming to Mount Sinai, Dr. Goodman was Director of the Division of Adult Translational Research and Treatment Development the National Institute of Mental Health (NIMH), where he led research that investigated the pathophysiology of mental illness and helped advance the translation of behavioral science into innovations in clinical care.

Prior to joining the NIMH in 2007, Dr. Goodman served as Chair of the Department of Psychiatry at the University of Florida in Gainesville and earlier, he had founded and served as Chief of the Obsessive Compulsive Disorders Clinic at Yale University’s Clinical Neuroscience Research Unit. He is the principal developer of Y-BOCS, the rating gold standard for OCD, and he conducted some of the first controlled trials of selective serotonin reuptake inhibitors.

Dr. Goodman is a member of the American College of Neuropsychopharmacology, Distinguished Fellow of the American Psychiatric Association and is a past Chair of the FDA’s Psychopharmacologic Drug Advisory Committee. Dr. Goodman has published more than 250 articles in scientific journals, including Biological Psychiatry, Archives of General Psychiatry, and Psychopharmacology.

A native New Yorker, Dr. Goodman graduated from Columbia University with a BS in electrical engineering. He received his medical degree from Boston University and completed his internship, residency, and a research fellowship at Yale University School of Medicine.

Mysell lecturers are nominated by the Harvard Psychiatry Mysell Committee. The speaker is then selected from the list of nominees by the Harvard Psychiatry Executive Committee, which is made up of the chiefs of psychiatry at the seven Harvard-affiliated hospitals. Dr. Goodman will meet with psychiatry trainees, senior and junior faculty and participate in Grand Rounds at Massachusetts General Hospital. The Harvard Psychiatry Research Day also consists of a poster session for residents, fellows and faculty, where Dr. Goodman will have the opportunity to talk with the trainees about their research.

About The Mount Sinai Medical Center
The Mount Sinai Medical Center encompasses The Mount Sinai Hospital and Mount Sinai School of Medicine. The Mount Sinai Hospital is one of the nation’s oldest, largest and most-respected voluntary hospitals. Founded in 1852, Mount Sinai today is a 1,171-bed tertiary-care teaching facility that is internationally acclaimed for excellence in clinical care. Last year, nearly 60,000 people were treated at Mount Sinai as inpatients, and there were nearly 450,000 outpatient visits to the Medical Center.

Mount Sinai School of Medicine is internationally recognized as a leader in groundbreaking clinical and basic science research, as well as having an innovative approach to medical education. With a faculty of more than 3,400 in 38 clinical and basic science departments and centers, Mount Sinai ranks among the top 20 medical schools in receipt of National Institute of Health (NIH) grants. For more information, please visit www.mountsinai.org.